441 filings
Page 21 of 23
8-K
nwnhul
30 May 12
AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
12:00am
8-K
p1kyh46x
9 May 12
AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
12:00am
8-K
9jcrhu3mzy w0o
12 Apr 12
AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal
12:00am
S-8
du6dx0lzs4 p1o32ho6r
26 Mar 12
Registration of securities for employees
12:00am
8-K
4olrsqygum
22 Mar 12
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results
12:00am
8-K
e1m0zhcj
13 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
jljrets7
25 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K
tsk4 8tefk
8 Nov 11
AcelRx Pharmaceuticals Reports Third Quarter 2011 Financial Results
12:00am
8-K
dtmpenq5g7sbo
30 Sep 11
AcelRx Pharmaceuticals Appoints Mark G. Edwards To Its Board of Directors
12:00am
8-K
gius3autipdtuf 16pzo
12 Aug 11
AcelRx Pharmaceuticals Reports Second Quarter 2011 Financial Results
12:00am
D
jx505im17t
13 Jul 11
$20.84M in debt / options / securities to be acquired, sold $20.84M, 2 investors
12:00am
8-K
pr6ojdt huxp
30 Jun 11
AcelRx Secures $20 Million Loan Financing Agreement, Expected to Extend Its Operating Cash Runway Into 2013
12:00am
8-K
8vmybr3gzm7j evum
3 Jun 11
AcelRx Announces $5.6 Million Department of Defense Grant to Develop ARX-04, a New Acute Pain Product Candidate
12:00am
10-Q
tgk5dx gb2arsi
16 May 11
Quarterly report
12:00am
8-K
wana3 8xavkapx7zb8jn
16 May 11
AcelRx Pharmaceuticals Reports First Quarter 2011 Financial Results
12:00am
10-K
nwots 3vl6g85
30 Mar 11
Annual report
12:00am